A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2006
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/24/2006	CA2237650C Benzamidoxime prodrugs as antipneumocystic agents
10/24/2006	CA2195663C Dihydrobenzofuranes
10/19/2006	WO2006110483A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109737A1 Pranlukast hydrate-containing preparation having relieved bitterness
10/19/2006	WO2006108506A1 Uses of 2-phenyl-substituted imidazotriazinone derivatives for treating pulmonary hypertension
10/19/2006	WO2006108358A1 ANTIVIRAL USE OF ARTIFICIAL CpG-CONTAINING SINGLE-STRANDED OLIGODEOXYNUCLEOTIDES IN COMBINATION WITH RIBAVIRIN
10/19/2006	WO2006094134A3 Kim-1 antibodies for treatment of th2-mediated conditions
10/19/2006	WO2006085212A3 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
10/19/2006	WO2006023791A3 Methods and compositions for treating allergic inflammation
10/19/2006	US20060235473 Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
10/19/2006	US20060235072 Potassium channel opener
10/19/2006	US20060235058 Substituted 5-membered ring compounds and their use
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060235045 Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060234991 Combinations for the treatment of immunoinflammatory disorders
10/19/2006	US20060234980 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
10/19/2006	US20060234955 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060233890 Method for treating a mammal by administration of a compound having the ability to release CO
10/19/2006	US20060233872 Pharmaceutical product which is used to reduced or stop moderate or severe snoring
10/19/2006	US20060233833 Novel uses of parapoxvirus preparations
10/19/2006	US20060233723 Mouth and/or throat wash
10/19/2006	DE202004021099U1 Medical product useful to e.g. treat asthma, comprises a dry powder medicament dose (comprising fine particle dose of tiotropium and at least one dry excipient) loaded into a container for use in a dry powder inhaler
10/19/2006	CA2604327A1 Pharmaceutical aerosol composition
10/19/2006	CA2603935A1 Uses of 2-phenyl-substituted imidazotriazinone derivatives for treating pulmonary hypertension
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006	CA2603402A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/18/2006	EP1712220A1 Pharmaceutical aerosol composition
10/18/2006	EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006	EP1711485A1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
10/18/2006	EP1711480A1 Novel long-working beta-2-agonists and use thereof as medicaments
10/18/2006	EP1711166A1 Stable amorphous forms of montelukast sodium
10/18/2006	EP1711164A2 Method of treating acute rhinosinusitis
10/18/2006	EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1239850B1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents
10/18/2006	EP1141286B1 Cytokine receptor chain
10/18/2006	EP1042468B1 Low-voltage activated calcium channel compositions and methods
10/18/2006	EP0931063B1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1847228A Ozagrel ornithine salt and its injection form
10/18/2006	CN1846781A Medicine for treating chronic pharyngitis
10/18/2006	CN1846768A Bamboo juice extracting method
10/18/2006	CN1846761A Medicine for treating cold and cough and its prepn process
10/18/2006	CN1846755A Chinese medicine for treating bronchial asthma in acute attack stage and its prepn process
10/18/2006	CN1846751A Groundcherry injection and its prepn process
10/18/2006	CN1846748A Cold-treating Fupu effervescent tablet and its prepn process and quality control method
10/18/2006	CN1846746A Chinese medicine ginseng-notopterygium powder for treating rhinitis
10/18/2006	CN1846732A Veterinary medicine for animal's epimedic disease and its prepn process and application
10/18/2006	CN1846730A Chaihuang soft capsule preparing process and its quality control technology
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846698A Application of cimetidine in treating cough-treating medicine
10/18/2006	CN1280303C Artificial composite deoxygenation oligonucleotide with CpG single chain being contained, and effect of anti SARS virus
10/18/2006	CN1280292C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
10/18/2006	CN1280291C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/18/2006	CN1280289C Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280259C Aryl aniline beta-2 adrenergic receptor agonists
10/18/2006	CN1279978C Purification method of dermatonecrotoxin and anatoxin produced by Bordetella
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279961C Chinese prepared drug formulation for stopping cough and eliminating sputum and its preparation process
10/18/2006	CN1279939C Medicinal spraying agent for treating nasitis
10/18/2006	CN1279933C Chinese materia medica preparation for treating cough and preparation method
10/18/2006	CN1279921C Extraction method of Anhui fritillary extract
10/18/2006	CN1279893C Surfactant compounds and uses thereof
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122558 Anticholinergic agents; chronic obstructive pulmonary diseases; incontinence; gastrointestinal disorders; antiulcer agents; cardiovascular disorders
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
10/17/2006	US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006	US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/17/2006	US7122347 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122311 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
10/17/2006	US7122206 Spraying into nose; triamcinolone acetonide
10/17/2006	US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006	WO2006107258A1 Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
10/12/2006	WO2006107257A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives
10/12/2006	WO2006107254A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
10/12/2006	WO2006107253A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
10/12/2006	WO2006107252A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
10/12/2006	WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
10/12/2006	WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/12/2006	US20060229346 Method for treating vascular hyperpermeable disease
10/12/2006	US20060229338 2,3'-bipyridines derivatives as selective cox-2 inhibitors
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229324 Quinazolin-4-one derivatives

1 ... 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 ... 878